Development of near-infrared photoactivable phthalocyanine-loaded nanoparticles to kill tumor cells: An improved tool for photodynamic therapy of solid cancers

Serena Duchi, Sara Ramos-Romero, Barbara Dozza, Marta Guerra-Rebollo, Luca Cattini, Marco Ballestri, Paolo Dambruoso, Andrea Guerrini, Giovanna Sotgiu, Greta Varchi, Enrico Lucarelli, Jeronimo Blanco

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Conventional photodynamic therapy has shown to be beneficial in the treatment of a variety of tumors. However, one of its major limitations is the inadequate penetration depth of visible light. In order to overcome this constraint, we developed 80 nm poly-methylmethacrylate core-shell fluorescent nanoparticles (FNP) loaded with the photosensitizer tetrasulfonated aluminum phthalocyanine (Ptl). To demonstrate the efficacy of our Ptl@FNP we performed in vitro and in vivo studies using a human prostate tumor model. Our data reveal that Ptl@FNP are internalized by tumor cells, favour Ptl intracellular accumulation, and efficiently trigger cell death through the generation of ROS upon irradiation with 680 nm light. When directly injected into tumors intramuscularly induced in SCID mice, Ptl@FNP upon irradiation significantly reduce tumor growth with higher efficiency than the bare Ptl. Collectively, these results demonstrate that the newly developed nanoparticles may be utilized as a delivery system for antitumor phototherapy in solid cancers.

Original languageEnglish
Pages (from-to)1885-1897
Number of pages13
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume12
Issue number7
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Photodynamic therapy
Photochemotherapy
Nanoparticles
Tumors
Cells
Infrared radiation
Neoplasms
Irradiation
Methylmethacrylate
Photosensitizing Agents
Photosensitizers
Light
Cell death
Phototherapy
SCID Mice
phthalocyanine
Prostate
Cell Death
Aluminum
Growth

Keywords

  • Bioluminescence imaging
  • Nanoparticles
  • Photodynamic therapy
  • Prostate cancer
  • Solid tumors
  • Tetrasulfonated aluminum phthalocyanine

ASJC Scopus subject areas

  • Molecular Medicine
  • Bioengineering
  • Biomedical Engineering
  • Materials Science(all)
  • Medicine (miscellaneous)
  • Pharmaceutical Science

Cite this

Development of near-infrared photoactivable phthalocyanine-loaded nanoparticles to kill tumor cells : An improved tool for photodynamic therapy of solid cancers. / Duchi, Serena; Ramos-Romero, Sara; Dozza, Barbara; Guerra-Rebollo, Marta; Cattini, Luca; Ballestri, Marco; Dambruoso, Paolo; Guerrini, Andrea; Sotgiu, Giovanna; Varchi, Greta; Lucarelli, Enrico; Blanco, Jeronimo.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 12, No. 7, 01.10.2016, p. 1885-1897.

Research output: Contribution to journalArticle

Duchi, Serena ; Ramos-Romero, Sara ; Dozza, Barbara ; Guerra-Rebollo, Marta ; Cattini, Luca ; Ballestri, Marco ; Dambruoso, Paolo ; Guerrini, Andrea ; Sotgiu, Giovanna ; Varchi, Greta ; Lucarelli, Enrico ; Blanco, Jeronimo. / Development of near-infrared photoactivable phthalocyanine-loaded nanoparticles to kill tumor cells : An improved tool for photodynamic therapy of solid cancers. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2016 ; Vol. 12, No. 7. pp. 1885-1897.
@article{8cf264c903b74fef858669bd86862804,
title = "Development of near-infrared photoactivable phthalocyanine-loaded nanoparticles to kill tumor cells: An improved tool for photodynamic therapy of solid cancers",
abstract = "Conventional photodynamic therapy has shown to be beneficial in the treatment of a variety of tumors. However, one of its major limitations is the inadequate penetration depth of visible light. In order to overcome this constraint, we developed 80 nm poly-methylmethacrylate core-shell fluorescent nanoparticles (FNP) loaded with the photosensitizer tetrasulfonated aluminum phthalocyanine (Ptl). To demonstrate the efficacy of our Ptl@FNP we performed in vitro and in vivo studies using a human prostate tumor model. Our data reveal that Ptl@FNP are internalized by tumor cells, favour Ptl intracellular accumulation, and efficiently trigger cell death through the generation of ROS upon irradiation with 680 nm light. When directly injected into tumors intramuscularly induced in SCID mice, Ptl@FNP upon irradiation significantly reduce tumor growth with higher efficiency than the bare Ptl. Collectively, these results demonstrate that the newly developed nanoparticles may be utilized as a delivery system for antitumor phototherapy in solid cancers.",
keywords = "Bioluminescence imaging, Nanoparticles, Photodynamic therapy, Prostate cancer, Solid tumors, Tetrasulfonated aluminum phthalocyanine",
author = "Serena Duchi and Sara Ramos-Romero and Barbara Dozza and Marta Guerra-Rebollo and Luca Cattini and Marco Ballestri and Paolo Dambruoso and Andrea Guerrini and Giovanna Sotgiu and Greta Varchi and Enrico Lucarelli and Jeronimo Blanco",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.nano.2016.04.014",
language = "English",
volume = "12",
pages = "1885--1897",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Development of near-infrared photoactivable phthalocyanine-loaded nanoparticles to kill tumor cells

T2 - An improved tool for photodynamic therapy of solid cancers

AU - Duchi, Serena

AU - Ramos-Romero, Sara

AU - Dozza, Barbara

AU - Guerra-Rebollo, Marta

AU - Cattini, Luca

AU - Ballestri, Marco

AU - Dambruoso, Paolo

AU - Guerrini, Andrea

AU - Sotgiu, Giovanna

AU - Varchi, Greta

AU - Lucarelli, Enrico

AU - Blanco, Jeronimo

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Conventional photodynamic therapy has shown to be beneficial in the treatment of a variety of tumors. However, one of its major limitations is the inadequate penetration depth of visible light. In order to overcome this constraint, we developed 80 nm poly-methylmethacrylate core-shell fluorescent nanoparticles (FNP) loaded with the photosensitizer tetrasulfonated aluminum phthalocyanine (Ptl). To demonstrate the efficacy of our Ptl@FNP we performed in vitro and in vivo studies using a human prostate tumor model. Our data reveal that Ptl@FNP are internalized by tumor cells, favour Ptl intracellular accumulation, and efficiently trigger cell death through the generation of ROS upon irradiation with 680 nm light. When directly injected into tumors intramuscularly induced in SCID mice, Ptl@FNP upon irradiation significantly reduce tumor growth with higher efficiency than the bare Ptl. Collectively, these results demonstrate that the newly developed nanoparticles may be utilized as a delivery system for antitumor phototherapy in solid cancers.

AB - Conventional photodynamic therapy has shown to be beneficial in the treatment of a variety of tumors. However, one of its major limitations is the inadequate penetration depth of visible light. In order to overcome this constraint, we developed 80 nm poly-methylmethacrylate core-shell fluorescent nanoparticles (FNP) loaded with the photosensitizer tetrasulfonated aluminum phthalocyanine (Ptl). To demonstrate the efficacy of our Ptl@FNP we performed in vitro and in vivo studies using a human prostate tumor model. Our data reveal that Ptl@FNP are internalized by tumor cells, favour Ptl intracellular accumulation, and efficiently trigger cell death through the generation of ROS upon irradiation with 680 nm light. When directly injected into tumors intramuscularly induced in SCID mice, Ptl@FNP upon irradiation significantly reduce tumor growth with higher efficiency than the bare Ptl. Collectively, these results demonstrate that the newly developed nanoparticles may be utilized as a delivery system for antitumor phototherapy in solid cancers.

KW - Bioluminescence imaging

KW - Nanoparticles

KW - Photodynamic therapy

KW - Prostate cancer

KW - Solid tumors

KW - Tetrasulfonated aluminum phthalocyanine

UR - http://www.scopus.com/inward/record.url?scp=84973497882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973497882&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2016.04.014

DO - 10.1016/j.nano.2016.04.014

M3 - Article

AN - SCOPUS:84973497882

VL - 12

SP - 1885

EP - 1897

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 7

ER -